Thermo Fisher Scientific Inc (TMO): Price and Financial Metrics

Thermo Fisher Scientific Inc (TMO)

Today's Latest Price: $441.63 USD

7.29 (1.68%)

Updated Sep 30 2:40pm

Add TMO to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 58 in Medical - Diagnostics/Research

See all "A" rated Strong Buy stocks

TMO Stock Summary

  • With a market capitalization of $171,820,299,996, Thermo Fisher Scientific Inc has a greater market value than 99.15% of US stocks.
  • TMO's went public 33.1 years ago, making it older than 91.59% of listed US stocks we're tracking.
  • Price to trailing twelve month operating cash flow for TMO is currently 32.59, higher than 88.75% of US stocks with positive operating cash flow.
  • Stocks that are quantitatively similar to TMO, based on their financial statements, market capitalization, and price volatility, are DHR, NVO, PEP, MDT, and NKE.
  • Visit TMO's SEC page to see the company's official filings. To visit the company's web site, go to
TMO Daily Price Range
TMO 52-Week Price Range

TMO Stock Price Chart Technical Analysis Charts

TMO Price/Volume Stats

Current price $441.63 52-week high $444.80
Prev. close $434.34 52-week low $250.21
Day low $435.07 Volume 683,387
Day high $444.80 Avg. volume 1,691,827
50-day MA $420.88 Dividend yield 0.2%
200-day MA $353.38 Market Cap 174.70B

Thermo Fisher Scientific Inc (TMO) Company Bio

Thermo Fisher Scientific provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide. The company was founded in 1956 and is based in Waltham, Massachusetts.

TMO Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$441.63$164.89 -62%

We started the process of determining a valid price forecast for Thermo Fisher Scientific Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Thermo Fisher Scientific Inc ranked in the 23th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Thermo Fisher Scientific Inc, consider:

  • The stock's equity weight, or the proportion of capital from equity relative to debt, is 89. Its equity weight surpasses that of 60.52% of free cash flow generating stocks in the Healthcare sector.
  • The business' balance sheet reveals debt to be 11% of the company's capital (with equity being the remaining amount). Approximately merely 24.65% of US stocks with free cash flow have a lower reliance on debt in their capital structure.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

Want more companies with a valuation profile/forecast similar to that of Thermo Fisher Scientific Inc? See GMED, HOLX, CAH, ENTA, and MDT.

TMO Latest News Stream

Event/Time News Detail
Loading, please wait...

TMO Latest Social Stream

Loading social stream, please wait...

View Full TMO Social Stream

Latest TMO News From Around the Web

Below are the latest news stories about Thermo Fisher Scientific Inc that investors may wish to consider to help them evaluate TMO as an investment opportunity.

Gene Expression Market Reflect a Holistic Expansion With Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., PerkinElmer, Bio-Rad Laboratories, OriGene Technologies, Illumina, Inc., QIAGEN

A report by The Insight Partner's on the Gene Expression Market discusses the growth of the market in great detail. It discusses thoroughly all factors promoting and deterring the market. The report also focuses on the competitive dynamics in the

OpenPR | September 29, 2020

Research antibody Market SWOT Analysis by Key Players: Thermo Fisher Scientific, Abcam, Merck

A new research document is added in HTF MI database of 200 pages, titled as 'Global Research antibody Market Size study with COVID-19 impact, by Product (Reagents and Antibodies), by Technology (Western Blotting, Flow Cytometry, Enzyme-Linked Immunosorbent Assay (ELISA), Immunohistochemistry

OpenPR | September 29, 2020

Transplant Diagnostics Market With Current Trends Analysis 2020: Omixon Ltd., CareDx, Affymetrix, Inc, Abbott Laboratories, Inc, Thermo Fisher Scientific, Inc

The Business Research Company offers " Transplant Diagnostics Global Market Report 2020-30: Covid 19 Growth And Change" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective

OpenPR | September 29, 2020

Global Function Driven Metagenomics Market Projected To Show Strong Growth By 2026 | |Danaher; Merck KGaA; Illumina, Inc.; Thermo Fisher Scientific Inc.; QIAGEN; F. Hoffmann-La Roche Ltd; Novogene Corporation

The numerous recent developments, products launches, research, joint ventures, mergers and acquisitions in the Function Driven Metagenomics market which is changing the face healthcare industry.We at Data Bridge Market Research understand what is important in the Function Driven

OpenPR | September 29, 2020

Surgical Face Shield Market (Impact of Covid-19) With Top Key Players like 3M, ANSELL LTD, Cardinal Health, KCWW, Medline Industries, Inc. Thermo Fisher Scientific, Honeywell International Inc., Henry Schein, Inc. Southmedic, HYGECO

The surgical face shield is a disposable, loose-fitting device, which creates a physical barrier between the nose and mouth of the wearer and potential contaminants in the immediate environment. Surgical face shields are available at different lengths and materials to

OpenPR | September 29, 2020

Read More 'TMO' Stories Here

TMO Price Returns

1-mo 3.00%
3-mo 20.76%
6-mo 56.67%
1-year 54.05%
3-year 135.37%
5-year 260.53%
YTD 36.20%
2019 45.55%
2018 18.21%
2017 35.03%
2016 -0.12%
2015 13.75%

TMO Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full TMO Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.892 seconds.